Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CLEC12A Protein (AA 65-265) (FITC,His tag)

CLEC12A Origine: Humain Hôte: HEK-293 Cells Recombinant > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
N° du produit ABIN7274350
  • Antigène Voir toutes CLEC12A Protéines
    CLEC12A (C-Type Lectin Domain Family 12, Member A (CLEC12A))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 65-265
    Origine
    • 15
    • 3
    • 1
    • 1
    Humain
    Source
    • 14
    • 2
    • 2
    • 2
    HEK-293 Cells
    Purification/Conjugué
    Cette CLEC12A protéine est marqué à la FITC,His tag.
    Fonction
    FITC-Labeled Human CLEC12A/MICL/CLL-1 Protein
    Séquence
    His65-Ala265
    Attributs du produit
    Recombinant FITC-Labeled Human CLEC12A/MICL/CLL-1 Protein is expressed from HEK293 with His tag at the N-Terminus.It contains His65-Ala265.
    Pureté
    > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
    Stérilité
    0.22 μm filtered
    niveau d'endotoxine
    Less than 1EU per μg by the LAL method.
    Top Product
    Discover our top product CLEC12A Protéine
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Supplied as 0.22μm filtered solution in PBS ( pH 7.4).
    Stock
    -80 °C
    Stockage commentaire
    Valid for 12 months from date of receipt when stored at -80°C.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
    Date de péremption
    12 months
  • Antigène
    CLEC12A (C-Type Lectin Domain Family 12, Member A (CLEC12A))
    Autre désignation
    CLEC12A (CLEC12A Produits)
    Synonymes
    MGC179455 Protein, CLL-1 Protein, CLL1 Protein, DCAL-2 Protein, MICL Protein, D230024O04 Protein, KLRL1 Protein, Micl Protein, C-type lectin domain family 12 member A Protein, C-type lectin domain family 12, member a Protein, C-type lectin domain family 12, member A Protein, CLEC12A Protein, Clec12a Protein
    Sujet
    CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML.
    Poids moléculaire
    24.6 kDa. Due to glycosylation, the protein migrates to 35-55 kDa based on Tris-Bis PAGE result.
Vous êtes ici: